These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 36758521)

  • 21. Deep phenotyping of myalgic encephalomyelitis/chronic fatigue syndrome in Japanese population.
    Kitami T; Fukuda S; Kato T; Yamaguti K; Nakatomi Y; Yamano E; Kataoka Y; Mizuno K; Tsuboi Y; Kogo Y; Suzuki H; Itoh M; Morioka MS; Kawaji H; Koseki H; Kikuchi J; Hayashizaki Y; Ohno H; Kuratsune H; Watanabe Y
    Sci Rep; 2020 Nov; 10(1):19933. PubMed ID: 33199820
    [TBL] [Abstract][Full Text] [Related]  

  • 22. mapMECFS: a portal to enhance data discovery across biological disciplines and collaborative sites.
    Mathur R; Carnes MU; Harding A; Moore A; Thomas I; Giarrocco A; Long M; Underwood M; Townsend C; Ruiz-Esparza R; Barnette Q; Brown LM; Schu M
    J Transl Med; 2021 Nov; 19(1):461. PubMed ID: 34749736
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systemic antibody responses against human microbiota flagellins are overrepresented in chronic fatigue syndrome patients.
    Vogl T; Kalka IN; Klompus S; Leviatan S; Weinberger A; Segal E
    Sci Adv; 2022 Sep; 8(38):eabq2422. PubMed ID: 36149952
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insights into Metabolite Diagnostic Biomarkers for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
    Yamano E; Watanabe Y; Kataoka Y
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33810365
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: the biology of a neglected disease.
    Arron HE; Marsh BD; Kell DB; Khan MA; Jaeger BR; Pretorius E
    Front Immunol; 2024; 15():1386607. PubMed ID: 38887284
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A systematic review of metabolomic dysregulation in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis/Systemic Exertion Intolerance Disease (CFS/ME/SEID).
    Huth TK; Eaton-Fitch N; Staines D; Marshall-Gradisnik S
    J Transl Med; 2020 May; 18(1):198. PubMed ID: 32404171
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inflammatory and cell-mediated immune biomarkers in myalgic encephalomyelitis/chronic fatigue syndrome and depression: inflammatory markers are higher in myalgic encephalomyelitis/chronic fatigue syndrome than in depression.
    Maes M; Twisk FN; Ringel K
    Psychother Psychosom; 2012; 81(5):286-95. PubMed ID: 22832503
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Review of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: an evidence-based approach to diagnosis and management by clinicians.
    Bested AC; Marshall LM
    Rev Environ Health; 2015; 30(4):223-49. PubMed ID: 26613325
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circulating levels of GDF15 in patients with myalgic encephalomyelitis/chronic fatigue syndrome.
    Melvin A; Lacerda E; Dockrell HM; O'Rahilly S; Nacul L
    J Transl Med; 2019 Dec; 17(1):409. PubMed ID: 31801546
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence for Peroxisomal Dysfunction and Dysregulation of the CDP-Choline Pathway in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
    Che X; Brydges CR; Yu Y; Price A; Joshi S; Roy A; Lee B; Barupal DK; Cheng A; Palmer DM; Levine S; Peterson DL; Vernon SD; Bateman L; Hornig M; Montoya JG; Komaroff AL; Fiehn O; Lipkin WI
    medRxiv; 2022 Jan; ():. PubMed ID: 35043127
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High-throughput 16S rRNA gene sequencing reveals alterations of intestinal microbiota in myalgic encephalomyelitis/chronic fatigue syndrome patients.
    Frémont M; Coomans D; Massart S; De Meirleir K
    Anaerobe; 2013 Aug; 22():50-6. PubMed ID: 23791918
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Validation of impaired Transient Receptor Potential Melastatin 3 ion channel activity in natural killer cells from Chronic Fatigue Syndrome/ Myalgic Encephalomyelitis patients.
    Cabanas H; Muraki K; Balinas C; Eaton-Fitch N; Staines D; Marshall-Gradisnik S
    Mol Med; 2019 Apr; 25(1):14. PubMed ID: 31014226
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased nuclear factor-κB and loss of p53 are key mechanisms in Myalgic Encephalomyelitis/chronic fatigue syndrome (ME/CFS).
    Morris G; Maes M
    Med Hypotheses; 2012 Nov; 79(5):607-13. PubMed ID: 22951418
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biomarkers for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): a systematic review.
    Maksoud R; Magawa C; Eaton-Fitch N; Thapaliya K; Marshall-Gradisnik S
    BMC Med; 2023 May; 21(1):189. PubMed ID: 37226227
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolic profiling of a myalgic encephalomyelitis/chronic fatigue syndrome discovery cohort reveals disturbances in fatty acid and lipid metabolism.
    Germain A; Ruppert D; Levine SM; Hanson MR
    Mol Biosyst; 2017 Jan; 13(2):371-379. PubMed ID: 28059425
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Examining clinical similarities between myalgic encephalomyelitis/chronic fatigue syndrome and D-lactic acidosis: a systematic review.
    Wallis A; Ball M; McKechnie S; Butt H; Lewis DP; Bruck D
    J Transl Med; 2017 Jun; 15(1):129. PubMed ID: 28592308
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Infection Elicited Autoimmunity and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: An Explanatory Model.
    Blomberg J; Gottfries CG; Elfaitouri A; Rizwan M; Rosén A
    Front Immunol; 2018; 9():229. PubMed ID: 29497420
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The utility of patient-reported outcome measures among patients with myalgic encephalomyelitis/chronic fatigue syndrome.
    Murdock KW; Wang XS; Shi Q; Cleeland CS; Fagundes CP; Vernon SD
    Qual Life Res; 2017 Apr; 26(4):913-921. PubMed ID: 27600520
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome in the Era of the Human Microbiome: Persistent Pathogens Drive Chronic Symptoms by Interfering With Host Metabolism, Gene Expression, and Immunity.
    Proal A; Marshall T
    Front Pediatr; 2018; 6():373. PubMed ID: 30564562
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Post-exertional malaise among people with long COVID compared to myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).
    Vernon SD; Hartle M; Sullivan K; Bell J; Abbaszadeh S; Unutmaz D; Bateman L
    Work; 2023; 74(4):1179-1186. PubMed ID: 36911963
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.